Ironwood Pharma (IRWD) CFO to Resign

Ironwood Pharma (NASDAQ: IRWD) disclosed:

On December 2, 2024, Sravan K. Emany notified Ironwood Pharmaceuticals, Inc. (the “Company”) that he is resigning from his position as Senior Vice President, Chief Operating Officer and Chief Financial Officer, effective December 18, 2024. Mr. Emany’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting. Effective December 18, 2024, Thomas McCourt, the Company’s Chief Executive Officer, will serve as the Company’s principal financial officer on an interim basis until a new principal financial officer is designated.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• BIGG Digital Assets to rename as Surge Digital, consolidate shares
• Hinge Health signs $86M office lease in San Francisco